Facebook-f X-twitter Youtube Google Linkedin-in
Sales 571-982-6000
Support 888-351-9014
Remote Support Login


SERVING CHARLOTTE, NC · UPTOWN · SOUTH END · BALLANTYNE · UNIVERSITY CITY · MATTHEWS

Biotech IT Support in Charlotte Lab Data Protected. Research Uninterrupted.

Months of research can vanish in one incident. We support Charlotte biotech and life-science teams — lab instrument connectivity, data integrity, IP protection, and compliance-ready infrastructure.

15+
YEARS
1,000+
BUSINESSES
<30 min
RESPONSE
4.9★
GOOGLE
  • 24/7 helpdesk & on-site Charlotte support
  • Industry compliance handled end to end
  • Vendor & line-of-business app management
  • A dedicated Success Manager who knows your world
Get Your Free Cyber Risk Score →Book Your Free 15-Minute Strategy Call →or call 571-982-6000

Free · Takes 3 minutes · No sales call required

Start My Free Biotech IT Assessment

For the Charlotte area biotech, life sciences, research, and medical-device organizations. Response within 30 minutes.













No spam. No contract required. Your information is used only to prepare for your assessment call and is never sold or shared.

SOUND FAMILIAR?

If Any of These Hit Home, You Are Losing Money Right Now

One Incident, a Year of Research

Ransomware or a failed disk on the wrong server does not cost files — it costs experiments, timelines, and credibility.

AI-Fluent Teams Reach Milestones Faster

From literature review to analysis pipelines, Charlotte teams using AI move faster to data — and investors notice velocity.

Unpublished Research in Public AI Tools

Pasting methods or results into a free chatbot can compromise IP and publication. Guardrails let scientists use AI safely.

AI

AI & Research Computing

Infrastructure and governance for AI-accelerated science.

  • AI/ML workstations & GPU infrastructure
  • IP-safe AI usage controls
  • Research data pipelines ready for AI

Book Your Free 15-Minute Strategy Call →

What We Do

Biotech and Life Sciences IT Services: Six Capabilities That Protect Your Research, Your IP, and Your Regulatory Standing

Each service maps directly to a specific threat or compliance requirement facing the Charlotte area research organizations. These are not adapted from a general managed IT catalog — they are built for the specific operational and regulatory environment of life sciences organizations in the defense-and-medical corridor of Coastal North Carolina.

FDA 21 CFR Part 11

Electronic Records Integrity and FDA 21 CFR Part 11 Compliance

We implement the access control, audit trail, and system validation infrastructure that FDA 21 CFR Part 11 requires for regulated electronic records — covering LIMS, EDC, ELN, QMS, and any other computerized system used in FDA-regulated workflows. Every regulated system gets unique user IDs with role-based access, automated audit trails that capture each record creation and modification with user identity and timestamp, system validation documentation demonstrating that software performs its intended functions accurately, and controls that prevent unauthorized record alteration.

What it prevents: FDA Form 483 observations for data integrity failures, warning letters, consent decree risk, and the manufacturing authorization delays that follow a pre-approval inspection finding electronic records non-compliance. The medical-device startup scenario above lost fourteen months of market entry time to exactly these findings.

Without it: every electronic record in your FDA-regulated workflow is a potential data integrity finding during an inspection. Inspectors will ask to see audit trails for specific records. If the audit trail does not exist or does not capture individual user actions, the record is legally suspect.

DLP + UBA

Research IP Protection and Insider Exfiltration Defense

We deploy data loss prevention (DLP) policies that monitor and control outbound transfer of proprietary research files — compound data, synthesis records, clinical trial results, formulation documentation — across email, cloud storage, USB, and web upload channels. User behavior analytics (UBA) establishes baseline patterns for each researcher’s data access activity and alerts on anomalies: bulk file access, unusual off-hours activity, mass copy operations to external destinations, or access to data outside the researcher’s normal work scope. For departing employees, we implement an offboarding security protocol that revokes access, captures a final activity review, and documents the chain of custody for any data the researcher had handled.

What it prevents: the scenario above — five years of proprietary compound data walking out the door with a departing researcher over two weeks of undetected cloud uploads, with a cyber insurance policy that offered no recourse because the researcher had authorized access.

Without it: authorized users are invisible to security tools that only monitor for external attackers. The most damaging IP theft in biotech is almost always perpetrated by someone who had every right to be in the file system — until they didn’t.

Lab Segmentation + Immutable Backup

Lab Network Segmentation and Ransomware Defense

We architect network segmentation that places laboratory instruments — sequencers, mass spectrometers, HPLC systems, imaging platforms, bioreactor control systems — on isolated VLANs with firewall policies that prevent lateral movement between the instrument network and administrative systems. Ransomware that enters through a phishing email on a researcher’s workstation cannot reach the LIMS or the sequencer data if the networks are properly segmented. Immutable, air-gapped backups of research data are configured with retention policies that support recovery to a known-good state from any point in the past 30 days. Backup restoration is tested on a scheduled basis — not assumed to work when the ransom note arrives.

What it prevents: the CRO scenario above — eleven months of recovery, $1.8M in direct costs, and permanent loss of participant data — caused by ransomware that encrypted everything because no network boundary stood between the entry point and the research data, and no tested backup existed to restore from.

Without it: a single phishing click on any networked device becomes a path to every instrument, every dataset, and every record in your research environment. Recovery from ransomware without a tested backup means paying the ransom and hoping the decryption key works — which it did not fully do in the CRO scenario above.

HIPAA + Part 11

HIPAA Compliance for Clinical Trial Sponsors and CROs

Clinical trial sponsors and contract research organizations handling participant PHI carry full HIPAA Security Rule obligations: annual Security Risk Analysis under 45 CFR 164.308(a)(1), technical safeguards for all ePHI systems, Business Associate Agreements with every downstream vendor with participant data access, workforce training, and a breach notification plan that addresses both the 60-day HIPAA reporting window and North Carolina Code 18.2-186.6’s requirement for AG notification without unreasonable delay. We build HIPAA compliance programs for Charlotte-area CROs, trial sponsors, and research sites that are specifically scoped to a research environment — not a physician practice template adapted for a lab context.

What it prevents: the HIPAA breach notification cascade that follows a ransomware event or data exfiltration incident involving trial participants’ PHI — the obligation that activates immediately when the encryption is discovered, regardless of whether the data has been confirmed exfiltrated.

Without it: a breach involving trial participant data triggers notification requirements that begin counting from the date of discovery — not the date you decide you are ready to report. Missing those windows is an independent violation on top of the underlying breach.

NIST CSF 2.0 + CMMC

NIST CSF 2.0 and CMMC for Federally Funded Research

We implement NIST CSF 2.0 security programs aligned to the Pentagon, NSF, and civilian federal grant expectations, and CMMC Level 2 programs (110 practices from NIST SP 800-171 Rev 2) for the Charlotte area research organizations receiving DoD contracts or DARPA funding. For organizations facing both civilian and DoD funding, we build a single integrated control framework that satisfies both requirements without duplicating effort. CMMC Phase 1 is active now; Phase 2 mandatory C3PAO assessment begins November 10, 2026. Organizations that wait until 2026 to begin preparation will not be assessment-ready before the deadline. We manage the full path from gap assessment through System Security Plan (SSP) development, Plan of Action and Milestones (POA&M), Microsoft 365 GCC or GCC High migration, and C3PAO readiness.

What it prevents: the DARPA contractor scenario above — CUI exfiltration through an unmanaged vendor access channel, 72-hour incident reporting obligation missed, False Claims Act exposure for affirming CMMC compliance while material gaps remained open in the control framework.

Without it: affirming CMMC or NIST 800-171 compliance on DoD contract documents while material gaps exist is False Claims Act territory — a legal exposure that extends beyond cybersecurity into federal contracting liability.

vCISO + Vendor Risk

Supply Chain and Vendor Risk Management

We conduct security assessments of every third-party vendor with access to your research network, LIMS platform, instrument systems, or research data — including cloud-hosted LIMS providers, CROS, lab equipment support vendors, and IT service providers. Access for each vendor is scoped to the minimum necessary, enforced with MFA and time-limited credentials, and logged in a format that supports both CMMC and FDA Part 11 audit requirements. Business Associate Agreements are executed with every vendor that touches participant PHI. For CMMC-obligated organizations, vendor access is documented in the System Security Plan as part of the supply chain risk management controls required by NIST SP 800-171 Rev 2. The Huntersville DARPA contractor’s breach entered through a LIMS vendor’s unmanaged support credentials — the exact gap this service prevents.

What it prevents: supply chain compromise through trusted vendor access — the vector that bypasses every perimeter control because the attacker is already authenticated. Third-party access is the fastest-growing initial access vector in research organization breaches.

Without it: every vendor with access to your research environment is a potential entry point for a threat actor who has already compromised that vendor. You cannot see those vendors’ security postures from the outside — but you can control what access they have and what they can do with it.

Who We Serve

Biotech and Life Sciences Sub-Verticals Across the Charlotte-area Research Corridor

The the Charlotte area life sciences ecosystem spans tissue banking, academic medical research, contract research, medical-device development, DoD-funded biomedical programs, and independent laboratory services. Each sub-vertical has a distinct regulatory and threat profile. Capital Techies serves all of them across all the Charlotte area region.

Tissue Banking and Biologics

Tissue Banks and Biologic Products

Leidos in Charlotte — one of the world’s largest nonprofit tissue banks with approximately 700 employees — is the anchor employer of the the Charlotte area biologics sector and the clearest example of what a mature life sciences IT environment looks like in this region. Tissue banks operating under FDA regulations for human cells, tissues, and cellular and tissue-based products (HCT/P) under 21 CFR Part 1271 carry quality system obligations that intersect with 21 CFR Part 11 requirements for electronic donor records, processing records, and release documentation. Capital Techies implements electronic records infrastructure that satisfies Part 11 audit trail requirements, access controls that enforce role-based minimum necessary access to donor records, and immutable backups of all regulated data. The stakes for a tissue bank are unique: a data integrity failure in a donor eligibility record is not a regulatory violation in the abstract — it is a patient safety event.

Academic Medical Research

Research Organizations and Academic Medical Centers

Eastern North Carolina Medical School in Cornelius operates as a freestanding academic medical center conducting active biomedical research across oncology, cardiovascular disease, reproductive medicine, and public health — representing the EVMS-adjacent research community that Capital Techies serves through affiliated investigators, commercial spinouts, and CRO relationships. Research organizations tied to EVMS, ODU’s biomedical research programs, or federal grant funding face HIPAA obligations for clinical data, NIST CSF 2.0 expectations from federal funders, IRB data security requirements for human subjects research under 45 CFR Part 46, and North Carolina breach notification requirements for any breach involving research participant personal information. Capital Techies builds security programs that address all of these requirements simultaneously, without requiring a dedicated in-house CISO that an early-stage or mid-size research organization cannot staff or afford.

Contract Research Organizations

CROs and Clinical Trial Sponsors

Contract research organizations and clinical trial sponsors in the Charlotte area — including those supporting trials for Peninsula-area health systems like North Carolina Hospital Center in Huntersville and EVMS-affiliated sites in Cornelius — face a particularly dense compliance stack. As HIPAA business associates or covered entities in their own right, CROs must satisfy the full Security Rule. As handlers of FDA-regulated trial data, they must satisfy 21 CFR Part 11. As organizations processing North Carolina residents’ personal data, they face breach notification obligations under Va. Code 18.2-186.6. And as organizations holding commercially valuable trial results — efficacy data, biomarker findings, dose-response curves — they face the IP theft threats documented in the scenarios above. Capital Techies designs security programs for Charlotte-area CROs that address all four dimensions without treating them as separate projects.

Medical Device

Medical-Device Development and Startups

the Charlotte area is home to an emerging medical-device development community, including organizations affiliated with Springfield University’s Proton Therapy Institute and defense-adjacent biomedical technology development firms serving the Department of Defense medical research community at Naval Medical Center Gastonia. Medical-device startups face 21 CFR Part 11 obligations for all regulated electronic records in their quality management systems, FDA cybersecurity guidance for connected devices (including the September 2023 Cybersecurity in Medical Devices guidance, which now requires a software bill of materials and vulnerability disclosure policies as part of 510(k) and PMA submissions), and the broader IP protection imperatives of any company whose entire value is concentrated in pre-commercial intellectual property. Capital Techies helps the Charlotte area medical-device startups build the electronic records infrastructure that survives a pre-approval inspection and the security architecture that protects the IP that gives those submissions their value.

DoD-Funded Biomedical Research

Defense-Adjacent Research Organizations

the Charlotte area is home to one of the densest concentrations of DoD research activity in the United States — and that extends into biomedical research. Organizations receiving DARPA grants, ONR contracts, CDMRP awards, or other DoD-adjacent research funding for biomedical programs handle CUI and carry CMMC and DFARS obligations that the majority of their commercial biotech counterparts never face. The the Charlotte area defense-medical corridor — including programs connected to Naval Medical Center Gastonia, George Mason University research networks, and DTRA-affiliated biodefense research — creates a specific category of life sciences organization that needs both the FDA compliance infrastructure of a research lab and the CMMC compliance infrastructure of a defense contractor. Capital Techies is one of the few managed IT providers in Charlotte and the Charlotte area with the cross-domain expertise to serve both requirements from a single provider.

Independent Labs and Lab Services

Independent Laboratories and Diagnostic Services

Independent clinical laboratories, reference labs, environmental testing laboratories, and specialty diagnostic services across the Charlotte area — including those serving the Peninsula, Southside, and Eastern Shore — operate under a combination of CLIA (Clinical Laboratory Improvement Amendments) requirements, HIPAA obligations for patient test results, and in some cases FDA requirements for laboratory-developed tests. Their IT environments are often built around a mix of legacy laboratory instruments, networked data capture systems, and commercial cloud platforms — a combination that creates the exact attack surface profile most attractive to ransomware operators. Capital Techies implements network segmentation, immutable backup, and access control programs for the Charlotte area independent laboratories that protect both the operational continuity and the patient data that their regulatory status depends on.

Threat Reality for Charlotte-area Life Sciences

Four Scenarios That Show Why Biotech IT Security Is Different From Every Other Industry

Standard managed IT stops at network uptime and device management. Biotech and life sciences organizations face threat scenarios — and regulatory consequences — that require a different approach entirely. These scenarios reflect documented threat patterns and regulatory fact patterns from FBI, CISA, HHS, and FDA enforcement actions.

The EVMS-Affiliated Research Team That Lost Three Years of Clinical Trial Data to Ransomware

A the Charlotte area contract research organization running a phase-two clinical trial for a regional medical institution had its entire data environment encrypted on a Thursday evening. The attack entered through an unpatched remote desktop server used by a data entry contractor. Within four hours, every record in the LIMS was encrypted — three years of raw assay data, participant records, dose logs, and adverse event reports. No immutable backup existed. The CRO notified the trial sponsor the next morning. Because the trial data included protected health information from North Carolina participants, HIPAA breach notification obligations to HHS OCR and affected individuals activated immediately. Under North Carolina Code 18.2-186.6, the North Carolina AG also required notification without unreasonable delay. The trial was suspended pending FDA review of data integrity. Recovery took eleven months and cost more than $1.8 million — and the compromised participant records never returned.

Consequence: trial suspension, FDA data integrity review, HIPAA breach notification cascade, North Carolina AG notification, $1.8M+ recovery cost, and permanent data loss. Ransomware appeared in 44% of all breaches in 2025 — and SMBs face an 88% rate. Source: Verizon DBIR 2025; HHS OCR breach notification requirements.

The Life Sciences Firm Whose Departing Researcher Took Five Years of Proprietary Formula Work

A Charlotte-based life sciences company had spent five years developing a novel compound formulation. A senior researcher who was departing for a competitor in another state copied 47 gigabytes of proprietary synthesis records, stability testing data, and unpublished compound characterization files to a personal cloud storage account over a two-week period before her last day. No data loss prevention tool monitored outbound transfer activity. No user behavior analytics flagged the abnormal volume. The company discovered the exfiltration six weeks later when a former colleague at the competitor’s firm mentioned seeing familiar compound names in an internal presentation. By then, the data was gone and the competitor had a six-month head start. The company’s cyber insurance policy excluded intellectual property theft that did not involve an “unauthorized” third party — because the researcher had authorized access to the files.

Consequence: five years of proprietary research lost to a competitor, cyber insurance denied on a technicality, competitive position permanently eroded. Insider exfiltration is the most undercounted threat in life sciences because authorized users are invisible to tools that only monitor external access. Source: FBI Intellectual Property Theft advisory; CISA Research Security guidance.

The DoD-Funded Biotech Research Lab Whose LIMS Vendor Was the Entry Point

A Huntersville biotech firm receiving a DARPA research contract had implemented NIST SP 800-171 controls on its primary workstations and servers. What it had not addressed was its laboratory information management system — a cloud-hosted LIMS whose vendor had access to the firm’s research data environment for support purposes through a shared-credential remote access account with no multi-factor authentication. A threat actor who had previously compromised the LIMS vendor’s support infrastructure used those credentials to move laterally into the biotech firm’s network, identify the folder structure containing CUI-tagged research outputs, and exfiltrate 28 gigabytes over a three-week period. Under DFARS 252.204-7012, the firm was required to report the incident to the DoD Cyber Crimes Center within 72 hours of discovery. They had never heard of that requirement. The prime contractor on the DARPA contract called two weeks later asking for the incident report number.

Consequence: CUI exfiltration via a trusted vendor, DFARS 72-hour incident reporting obligation missed, prime contractor notification failure, False Claims Act exposure for affirming CMMC compliance while the LIMS access gap remained open. Source: DFARS 252.204-7012; DoD Cyber Crimes Center reporting requirements.

The Medical-Device Startup Whose FDA Inspection Found Data Integrity Failures Before Launch

A the Charlotte area medical-device startup had built its quality management system on a commercial cloud platform without validating the system under FDA 21 CFR Part 11. When the FDA conducted a pre-approval inspection, investigators found that the electronic batch records in the system had no audit trail — the platform logged access but did not record what was changed, by whom, or when. Investigators also found that multiple users shared a single login for the quality management system, meaning individual user accountability for record modifications could not be demonstrated. The inspection resulted in a Form 483 with three data integrity observations. The startup’s manufacturing authorization was delayed by fourteen months while it rebuilt its electronic records infrastructure from the ground up. The cost of the delay, including capital held in finished goods that could not be released, exceeded $2.3 million.

Consequence: FDA Form 483 with data integrity observations, fourteen-month manufacturing authorization delay, $2.3M+ cost of delay. FDA 21 CFR Part 11 requires audit trails, access controls, and system validation documentation before any regulated electronic records system goes into production. Source: FDA 21 CFR Part 11; FDA data integrity guidance documents.

What Biotech IT Security Actually Means

Life Sciences IT Security Is Not Standard Managed IT With a Compliance Checklist Stapled On

Biotech and life sciences IT security is the discipline of protecting the data, systems, and intellectual property that define a research organization’s competitive and regulatory standing — while simultaneously satisfying the overlapping compliance requirements that govern how that data is created, maintained, and disclosed. It is fundamentally different from standard managed IT because the assets at risk are not replaceable: a destroyed financial record can be reconstructed; a three-year clinical trial data set cannot. A stolen compound formulation does not just create a recovery cost — it hands a competitor your entire investment in that program. And a failed FDA inspection finding data integrity failures in your electronic records does not just cost money — it can delay or permanently prevent your path to market.

The the Charlotte area research ecosystem creates specific context for these challenges. Eastern North Carolina Medical School (EVMS) in Cornelius — a freestanding academic medical center and one of North Carolina’s key biomedical research institutions — produces research outputs and clinical trial activity that create HIPAA, FDA, and IRB compliance obligations for affiliated investigators and their commercial partners. Old Dominion University’s research programs, including active work in biomedical sciences and bioelectrics, represent federal grant-funded research environments where NIST CSF 2.0 and the Pentagon data security expectations apply. Leidos in Charlotte — one of the world’s largest nonprofit tissue banks — operates in a regulated environment where tissue processing data, donor records, and quality system records carry both regulatory and reputational stakes. Springfield University’s Proton Therapy Institute brings capital-intensive medical technology into clinical and research use on the Peninsula. And the defense-research overlap in the Charlotte area means that biotech firms receiving DARPA, ONR, or other DoD research funding face CMMC and DFARS obligations that most commercial life sciences organizations never encounter.

The compliance frameworks that govern the Charlotte area life sciences organizations are not alternative choices — they stack. An organization running FDA-regulated trials that involve human subjects and receive DoD funding may simultaneously owe compliance to FDA 21 CFR Part 11 (data integrity), HIPAA (participant PHI), NIST CSF 2.0 (federal grant expectations), CMMC Level 2 (DoD CUI), and North Carolina Code 18.2-186.6 (breach notification). Standard managed IT providers know one or two of these frameworks at most. Capital Techies maps each the Charlotte area life sciences organization’s specific regulatory environment and builds security programs that address all applicable frameworks simultaneously — without building redundant controls or leaving gaps between them.

What biotech IT security includes in practice: network segmentation that isolates laboratory instrument networks from administrative systems; access controls and user behavior analytics that detect insider exfiltration before the researcher walks out the door; FDA 21 CFR Part 11-compliant audit logging and system validation documentation for LIMS, ELN, and QMS platforms; HIPAA-compliant infrastructure for clinical trial sponsors handling participant PHI; immutable backup architectures that protect research data from ransomware encryption; data loss prevention policies that control outbound transfer of proprietary research files; CMMC/NIST 800-171 control implementation for DoD-funded research environments; and vendor access management that prevents supply chain compromise through LIMS and instrument support channels.

What it is not: a generic antivirus deployment, a cloud backup subscription marketed as “HIPAA compliant,” or a compliance checklist completed once and filed. The threat actors targeting biotech organizations include nation-state intelligence services that have spent years developing spearphishing lures tailored to research communities, ransomware groups that specifically target organizations with irreplaceable data because they pay faster, and insider threats that are statistically more likely in research environments with high-value mobile data and competitive labor markets. These threats require active defenses — not passive checklists. Capital Techies designs and operates those defenses for the Charlotte area life sciences organizations.

The Numbers

Six Verified Statistics Every Charlotte-area Biotech and Research Leader Needs to Know

Every figure below is sourced and attributable. These are the numbers your CSO, compliance officer, and board of directors need before a breach, an FDA inspection, or a DoD contract audit arrives.

$10.22M
Average cost of a U.S. data breach in 2025 — the highest average in the world for the 15th consecutive year. Healthcare and life sciences organizations consistently rank at the top of industry-specific breach costs, well above the global average of $4.44M.
Source: IBM Cost of a Data Breach Report 2025

44%
Share of all data breaches in which ransomware appeared in 2025 — up from 32% the prior year, now the single most common action type in breaches globally. For SMBs — the category that covers most the Charlotte area research firms — the rate reaches 88% of breaches.
Source: Verizon Data Breach Investigations Report (DBIR) 2025

$1.53M
Average ransomware recovery cost in 2025 excluding any ransom payment — and that excludes the value of irreplaceable research data. For a life sciences organization, the cost of lost trial data or stolen IP compounds on top of direct recovery costs in ways that standard actuarial tables do not capture.
Source: Sophos State of Ransomware 2025

241 days
Mean time to identify and contain a breach in 2025 per IBM — the lowest in nine years, which means even the best-case detection window is still eight months of dwell time inside a research network. Nation-state actors targeting research IP operate on timelines measured in months, not days.
Source: IBM Cost of a Data Breach Report 2025

$1M
Median ransom payment in 2025 for organizations that paid — down from prior years as organizations improve defenses, but still the median. Organizations with backups tested and validated before an attack pay nothing. Organizations without them pay the median or more.
Source: Sophos State of Ransomware 2025

$4.44M
Global average data breach cost in 2025 — the U.S. average is 2.3 times higher at $10.22M. For the Charlotte area biotech firms competing for federal grants and DoD contracts, a breach is not just a recovery cost; it is a disqualifying event for future awards if incident response and security posture requirements were not met.
Source: IBM Cost of a Data Breach Report 2025

COMPLIANCE, HANDLED

The Compliance Frameworks That Apply to Charlotte-area Biotech and Life Sciences Organizations

You do not need to memorize the acronyms. You need to pass the audit and keep your clients’ trust. That is our job.

FDA 21 CFR PART 11

Unique user ID implementation across all regulated systems; audit trail configuration that captures record creation and modification with user identity and timestamp; …

HIPAA SECURITY RULE

Security Risk Analysis (SRA) mapped to 164.308(a)(1); technical safeguard implementation including access control, encryption, audit logging, and automatic logoff; Bus…

NIST CSF 2.0

Current-state profile assessment against the six CSF 2.0 functions (Govern, Identify, Protect, Detect, Respond, Recover); gap analysis against target profile; prioriti…

CMMC LEVEL 2 / NIST SP 800

Level 2 gap assessment against all 110 NIST SP 800-171 Rev 2 practices; System Security Plan (SSP) development; Plan of Action and Milestones (POA&M) with remediat…

See the full framework detail
Framework Who Needs It What Capital Techies Does Deliverable
FDA 21 CFR Part 11 (Electronic Records and Electronic Signatures) Any the Charlotte area biotech, CRO, medical-device firm, or laboratory using computerized systems to create, modify, maintain, archive, or transmit records required by FDA regulations — including LIMS, EDC, ELN, and QMS platforms in regulated workflows. Applies regardless of organization size or FDA clearance status. Unique user ID implementation across all regulated systems; audit trail configuration that captures record creation and modification with user identity and timestamp; system validation documentation (Installation Qualification / Operational Qualification); access control architecture enforcing minimum necessary access; controls preventing unauthorized record alteration; electronic signature implementation meeting Part 11 requirements Part 11 gap assessment report, system validation documentation package (IQ/OQ), audit trail configuration evidence, access control policy and user access matrix, electronic signature policy
HIPAA Security Rule (45 CFR Part 164, Subpart C) Clinical trial sponsors, CROs, and research sites handling participant PHI; organizations providing services to HIPAA-covered health systems in the Charlotte area (Inova Charlotte Hospital, North Carolina Hospital Center, Inova Health) as business associates. Applies to any entity that creates, receives, maintains, or transmits ePHI on behalf of a covered entity. Security Risk Analysis (SRA) mapped to 164.308(a)(1); technical safeguard implementation including access control, encryption, audit logging, and automatic logoff; Business Associate Agreement execution and inventory management; workforce HIPAA training documentation; breach notification plan aligned to both 60-day federal window and North Carolina Code 18.2-186.6 Annual SRA report, BAA inventory and executed agreements, technical safeguard evidence package, training completion records, breach response runbook
NIST CSF 2.0 (Cybersecurity Framework version 2.0, February 2024) Research organizations receiving the Pentagon, NSF, DOE, or other civilian federal grants; organizations required to demonstrate security posture as a condition of grant award or Data Use Agreement. NIST CSF 2.0 is the framework the Pentagon references when describing expected security practices for grant recipients. Not a mandatory certification but functionally required for federal research funding. Current-state profile assessment against the six CSF 2.0 functions (Govern, Identify, Protect, Detect, Respond, Recover); gap analysis against target profile; prioritized remediation roadmap; implementation of controls across all six functions; ongoing advisory to maintain alignment as the research environment evolves CSF 2.0 current-state and target-state profiles, gap analysis with remediation priorities, implementation evidence documentation, ongoing advisory reports
CMMC Level 2 / NIST SP 800-171 Rev 2 the Charlotte area biotech and research organizations receiving DoD contracts (DARPA, ONR, CDMRP, DTRA) or subcontracts involving Controlled Unclassified Information. CMMC Phase 1 is active since November 10, 2025; mandatory C3PAO third-party certification for Level 2 programs begins November 10, 2026. False Claims Act liability for organizations that affirm compliance while material gaps remain. Level 2 gap assessment against all 110 NIST SP 800-171 Rev 2 practices; System Security Plan (SSP) development; Plan of Action and Milestones (POA&M) with remediation tracking; Microsoft 365 GCC or GCC High migration for CUI environments; control implementation across all 14 security requirement families; C3PAO assessment readiness preparation Gap assessment report with SPRS score, System Security Plan (SSP), POA&M, GCC migration documentation, C3PAO readiness package
North Carolina Code 18.2-186.6 (Data Breach Notification) Every the Charlotte area biotech, research, lab, and medical-device organization that owns or licenses computerized data containing personal information of North Carolina residents — which covers all organizations handling research participant data, employee records, or clinical trial participant information. No size threshold. Applies regardless of sector. Incident response plan with North Carolina-specific notification workflow; notification letter preparation for affected residents; North Carolina AG Computer Crime Section notification package preparation; breach response coordination covering both HIPAA (where applicable) and North Carolina breach timelines simultaneously; annual incident response tabletop exercise Incident response plan with dual-track notification workflow (federal and North Carolina), AG notification package template, breach response runbook, tabletop exercise report
Cyber Insurance Requirements Every the Charlotte area life sciences organization carrying cyber liability coverage or seeking renewal at standard premiums. Carriers now universally require documented MFA, endpoint detection and response (EDR), tested and immutable backups, and security awareness training as conditions of both coverage issuance and claim payment. Missing controls discovered during post-claim audit are grounds for coverage denial. MFA implementation across Microsoft 365 and all research systems; EDR deployment (SentinelOne) with 24/7 SOC coverage; immutable backup implementation with tested restoration; patch management program documentation; annual security awareness training with documented completion records; controls attestation package for renewal questionnaires Controls attestation package with evidence, renewal-ready questionnaire responses, gap remediation documentation for any carrier-required improvements
IP Protection — Non-Regulatory Framework Every the Charlotte area biotech, life sciences, and research organization whose primary competitive asset is proprietary research data, compound formulations, device designs, or unpublished clinical results. Not a regulatory mandate — but the threat actors who target research IP operate with the same sophistication as nation-state adversaries, because in many cases they are. FBI and CISA have published joint advisories specifically on threats to the biomedical research sector. Data loss prevention (DLP) policy implementation across all outbound channels; user behavior analytics (UBA) baseline and anomaly detection; insider threat program including offboarding security protocols; data classification policy for proprietary research assets; access control architecture enforcing minimum necessary access to IP; supply chain vendor access management with MFA enforcement DLP policy documentation, UBA baseline and alerting configuration, insider threat program policy, data classification matrix, access control architecture documentation

Free Biotech IT Assessment

Find Out Exactly Where Your Life Sciences IT Program Has Gaps — Before a Breach or an Inspection Does

Most the Charlotte area biotech and life sciences organizations have security gaps they do not know about — in their LIMS vendor access controls, their FDA Part 11 audit trails, their insider exfiltration defenses, or their CMMC readiness. Our free Biotech IT Assessment identifies your specific exposure areas and gives you a written summary with no obligation.

  • 15-to-20-minute call with a Capital Techies advisor who understands FDA Part 11, HIPAA for clinical trials, NIST CSF 2.0, and CMMC
  • We map your compliance obligations based on your funding sources, data types, and regulated activities
  • We identify your highest-risk gaps: IP exfiltration controls, lab network segmentation, Part 11 audit trails, vendor access management
  • You receive a written gap summary whether or not you become a client
  • No contract required. No sales pressure — ever.
  • Serving biotech, CROs, research labs, medical-device firms, and tissue banks across all seven the Charlotte area cities
Start My Free Assessment

Client Feedback

What Our Clients Say

Real reviews from Capital Techies clients on Google.

FAQ

Biotech and Life Sciences IT Questions from Charlotte-area Research Organizations

Authoritative answers to the questions the Charlotte area biotech firms, CROs, research labs, and medical-device companies ask most often about IT security, FDA compliance, IP protection, and regulatory obligations.

What cybersecurity frameworks apply to the Charlotte area biotech and life sciences companies?
The applicable frameworks depend on what data and systems your organization operates. FDA 21 CFR Part 11 governs electronic records and electronic signatures in regulated research environments — any biotech or life sciences firm using computerized systems for data capture, LIMS, or electronic batch records in an FDA-regulated context must comply. HIPAA applies if your organization handles protected health information as a clinical trial sponsor, site, or CRO. NIST CSF 2.0 is the baseline cybersecurity framework recommended by the federal government and referenced by the Pentagon for grant-funded research organizations. CMMC Level 2 (110 practices from NIST SP 800-171) applies if your organization receives DoD research contracts or handles Controlled Unclassified Information. North Carolina Code 18.2-186.6 requires breach notification to affected residents and the North Carolina AG for any breach of unencrypted personal information, regardless of sector. Capital Techies maps each the Charlotte area biotech and life sciences organization to the specific frameworks that apply to their regulatory context, data types, and funding sources.
What is FDA 21 CFR Part 11 and does my research organization need to comply?
FDA 21 CFR Part 11 is the federal regulation governing electronic records and electronic signatures in FDA-regulated activities. It applies to any organization that uses computerized systems to create, modify, maintain, archive, retrieve, or transmit records required by FDA regulations — including records from clinical trials, laboratory testing, manufacturing, and quality control. Compliance requires audit trails that capture who created or modified each record and when; access controls that prevent unauthorized record modification; system validation documentation demonstrating that software performs its intended functions accurately; and controls ensuring that electronic signatures have the same legal weight as handwritten signatures. If your the Charlotte area biotech, CRO, lab, or medical-device firm uses LIMS, EDC, ELN, or any other computerized system in an FDA-regulated workflow, Part 11 likely applies. Non-compliance exposes the organization to FDA Form 483 observations during inspections and, in serious cases, warning letters and consent decrees. Capital Techies implements the access control, audit logging, and system validation documentation infrastructure that supports Part 11 compliance for the Charlotte area life sciences organizations.
How do research IP theft attacks actually happen at biotech companies?
Research IP theft follows several documented patterns. Insider exfiltration is the most common: a researcher departing for a competitor or a foreign-affiliated institution copies proprietary compound data, clinical trial results, or formulation records to personal cloud storage or an external drive before leaving. Nation-state sponsored actors — particularly those linked to China, Russia, and Iran — use spearphishing campaigns targeting research staff and grant administrators to gain persistent access to file servers and research data repositories; once inside, they conduct slow, deliberate exfiltration over weeks or months without triggering alerts. Supply chain compromise is growing: a vendor with access to your LIMS or laboratory network becomes the entry point. And direct ransomware targeting lab networks specifically exploits the irreproducibility of research data — an attacker who encrypts three years of clinical trial records holds an organization hostage in ways that a standard business cannot quantify. FBI and CISA have published joint advisories specifically on threats to the biomedical research sector from nation-state actors.
Do biotech companies that receive the Pentagon or federal research grants need cybersecurity programs?
Yes. the Pentagon grant recipients are required to protect the confidentiality of research data, particularly data involving human subjects, under the terms of the grant award and applicable federal regulations including the Common Rule (45 CFR Part 46) for human subjects research. NIST SP 800-171 and the NIST Cybersecurity Framework are the frameworks the Pentagon references when describing expected security practices for research institutions. Grant recipients handling data subject to a Data Use Agreement (DUA) typically have specific security requirements written into the agreement. Failure to implement adequate security controls can result in grant suspension, corrective action requirements, and — if a breach of research participant data occurs — breach notification obligations under HIPAA (if PHI is involved) and North Carolina Code 18.2-186.6. the Charlotte area research organizations affiliated with institutions like Eastern North Carolina Medical School, Old Dominion University, or independent research entities operating in the Cornelius Innovation Corridor face these requirements on most federally funded awards. Capital Techies builds security programs that satisfy the NIST CSF 2.0 baseline and federal grant security expectations for the Charlotte area research organizations.
What HIPAA obligations does a clinical trial sponsor or CRO in the Charlotte area have?
A clinical trial sponsor or contract research organization (CRO) that creates, receives, maintains, or transmits protected health information is a HIPAA covered entity or business associate and carries the full set of Security Rule obligations: annual Security Risk Analysis documented under 45 CFR 164.308(a)(1), technical safeguards for all ePHI systems, workforce training, Business Associate Agreements with all downstream vendors with ePHI access, and a documented incident response and breach notification plan. Clinical trial data commonly includes participants’ names, dates of birth, diagnosis codes, laboratory results, and genetic information — all are PHI. If a trial site or sponsor suffers a breach, HIPAA requires notification to HHS OCR and affected individuals within 60 days of discovery. North Carolina Code 18.2-186.6 adds a state-law notification obligation to the North Carolina AG and affected North Carolina residents without unreasonable delay. Capital Techies builds HIPAA compliance programs specifically sized for the Charlotte area clinical trial sponsors, CROs, and research sites.
What is the difference between NIST CSF 2.0 and CMMC for a biotech company?
NIST CSF 2.0 (published February 2024) is a voluntary framework organized around six functions: Govern, Identify, Protect, Detect, Respond, and Recover. It is not a compliance mandate for most private organizations but is referenced by the Pentagon, NSF, and other federal funding agencies as the expected security posture for research organizations. CMMC Level 2 is a mandatory DoD certification requirement — not voluntary — for contractors and subcontractors handling Controlled Unclassified Information under DoD contracts and grants. It encompasses 110 practices from NIST SP 800-171 Rev 2 and requires third-party assessment by an accredited C3PAO starting in November 2026. For a the Charlotte area biotech or life sciences organization, NIST CSF 2.0 is the right framework if your primary funding is the Pentagon, NSF, or civilian federal agencies. CMMC applies if you receive DoD research contracts, DARPA grants, or contracts from defense-adjacent agencies that flow CUI. Some organizations face both — DoD-funded research organizations often need CMMC in addition to the NIST CSF baseline that satisfies their civilian grant obligations. Capital Techies assesses each organization’s specific funding portfolio and data types to determine which frameworks apply.
How does ransomware affect biotech and laboratory operations differently than other businesses?
Ransomware in a laboratory or research environment causes damage that standard business continuity frameworks do not account for. Most business data — invoices, contracts, emails — can be reproduced or reconstructed. Research data often cannot: a three-year clinical trial data set, a novel compound’s synthesis records, a cell line’s passage history, or an in-progress assay’s raw outputs represent irreplaceable intellectual and scientific value. When ransomware encrypts a lab network on a Friday evening, the cost is not just the recovery time and ransom payment — it is the potential loss of data that cannot be regenerated at any price. Additionally, laboratory instruments increasingly connect to networks for data capture and remote monitoring, creating attack surfaces that most IT providers do not know how to segment and protect. Ransomware appeared in 44% of all breaches in 2025 per the Verizon DBIR — and small to medium research organizations face an 88% rate in their breach incidents. Capital Techies designs network segmentation architectures that isolate instrument networks from administrative systems, and implements immutable backup strategies that protect research data from encryption attacks.
What does North Carolina Code 18.2-186.6 require for a biotech company that suffers a data breach?
North Carolina Code 18.2-186.6 requires any entity that owns or licenses computerized data containing personal information of North Carolina residents to notify affected residents and the North Carolina Attorney General’s Computer Crime Section without unreasonable delay after a breach of unencrypted personal information. The law does not specify a fixed number of days — the “without unreasonable delay” standard applies, and delay is only permissible at law enforcement’s written request when notification would impede a criminal investigation. The AG must be notified for every reportable breach regardless of how few individuals are affected. If more than 1,000 persons are notified at one time, national consumer reporting agencies must also be notified. For biotech and research organizations, covered personal information includes participant names combined with Social Security numbers, financial account numbers, driver’s license numbers, passport numbers, or military identification numbers. Civil penalties can reach $150,000 per breach. Capital Techies builds incident response plans with North Carolina-specific notification workflows so the Charlotte area research organizations can satisfy both federal and state obligations simultaneously.
How does Capital Techies protect laboratory instruments and LIMS from cyber threats?
Laboratory instruments — sequencers, mass spectrometers, HPLC systems, imaging platforms, bioreactor control systems — are increasingly networked for data capture and remote access but are rarely updated, often run end-of-life operating systems, and are almost never managed by standard enterprise IT tools. LIMS and ELN platforms add additional attack surface. Capital Techies addresses lab environments with a layered approach: network segmentation that places instrument networks on isolated VLANs with firewall policies preventing lateral movement to administrative systems; asset inventory of all networked lab devices; compensating controls for instruments that cannot accept endpoint agents; strict access control policies that limit remote access to instruments to named individuals using MFA; and audit logging that captures all system access events in a format that supports FDA 21 CFR Part 11 audit trail requirements. We also address LIMS and ELN security validation — ensuring that the systems that capture your research data are configured in ways that preserve data integrity and satisfy Part 11 requirements. The result is a laboratory environment where research instruments are isolated from ransomware propagation paths and where data integrity is protected by both technical controls and documented evidence.
What does a free Biotech IT Assessment from Capital Techies include?
Capital Techies’ free Biotech IT Assessment is a 15-to-20-minute structured conversation with an advisor who understands the specific security and compliance requirements of the Charlotte area biotech, life sciences, research, and medical-device organizations. We cover: the regulatory frameworks that apply to your organization based on your funding sources, data types, and FDA-regulated activities; your current security posture against the key threat vectors for research organizations — IP theft, insider exfiltration, lab ransomware, and supply chain compromise; your biggest exposure areas in FDA 21 CFR Part 11, HIPAA, NIST CSF 2.0, or CMMC depending on what applies; and a written summary of your top gaps delivered after the call. There is no contract required, no sales pressure, and no obligation. The assessment is designed so that you leave with actionable information regardless of whether you engage Capital Techies as your IT provider.
Can Capital Techies serve biotech organizations in Huntersville, Concord, or other the Charlotte area cities beyond Charlotte?
Yes. Capital Techies serves biotech, life sciences, research, lab, and medical-device organizations across all the Charlotte area region of the Charlotte area: Charlotte, Cornelius, Concord, Springfield, Huntersville, Gastonia, and Rock Hill — as well as the broader Coastal North Carolina research corridor including Williamsburg, James City County, and the Eastern Shore. Organizations affiliated with EVMS in Cornelius, ODU research programs, Springfield University’s Proton Therapy Institute, or Huntersville-area life sciences and defense-adjacent research firms are all within our standard service area. We also serve early-stage biotech organizations at the formation stage that need to build security infrastructure from the ground up — not just established organizations seeking to remediate existing gaps.
What is the the Charlotte area biotech ecosystem and what makes it distinct from other U.S. research clusters?
the Charlotte area is not a traditional research cluster in the Boston or Research Triangle sense — it is a defense-and-medical corridor where the distinction between life sciences research and defense science is often blurred, and where the threat landscape for research IP reflects that overlap. Leidos (Charlotte, approximately 700 employees) is the clearest pure-play biotech anchor. Eastern North Carolina Medical School in Cornelius and ODU’s research programs provide academic research infrastructure with over $60 million in annual research expenditures at ODU alone. Springfield University’s Proton Therapy Institute brings clinical medical technology to the Peninsula. The defense-medical research overlap — DARPA-funded biomedical programs, ONR-adjacent life sciences contracts, the Naval Medical Center Gastonia research community — creates a category of research organization that combines FDA compliance obligations with DoD security requirements in ways that most managed IT providers cannot serve from a single platform. The Cornelius Innovation Corridor (the state-designated tech zone from Cornelius State University to ODU along the Elizabeth River) is the emerging commercial anchor for the region’s biotech and research startup ecosystem. Capital Techies was built to serve this specific ecosystem — where the compliance stack is denser than a standard biotech cluster and the threat landscape is shaped by proximity to the world’s largest concentration of military and intelligence activity.

How Exposed Is Your Business Right Now?

Get your free Cyber Risk Score in under 3 minutes. We check for exposed credentials, email spoofing gaps, dark web leaks, and unpatched systems. You get a letter grade and a plain-English report. No sales call required.

Get Your Free Cyber Risk Score →

Free · Takes 3 minutes · No sales call required